SGJapanese beverage company Kirin is launching a new yogurt drink called Kirin Immuse Yoghurt Flavour in Singapore, specifically developed for the local market. The product contains a proprietary ingredient, L. lactis Plasma, which claims to activate immune system 'leaders' to fight viruses. It will initially be sold via Fullerton Health's online marketplace before expanding to drugstores, supermarkets, and e-commerce platforms. Kirin highlights the drink's yogurt taste and its appeal to Singapore's growing demand for health-focused beverages. The company has diversified beyond beer into health science and pharmaceuticals.
Bias read (Center): The article discusses a commercial product launch with no mention of political figures, policies, or contentious issues. It focuses solely on a business development and product features, with no apparent framing or bias toward any political stance.
Why these scores (Factual 95 · Objective 85): Factuality is high as the article accurately reports Kirin's announcement about launching a new yogurt drink in Singapore, citing the date, product details, and distribution plans. Objectivity is slightly lower due to some promotional language such as 'satisfying yogurt taste' and emphasis on health
